2013
DOI: 10.1097/ta.0b013e31829e2186
|View full text |Cite
|
Sign up to set email alerts
|

Early treatment with lyophilized plasma protects the brain in a large animal model of combined traumatic brain injury and hemorrhagic shock

Abstract: In a clinically realistic combined TBI + HS model, early administration of plasma products decreases brain lesion size and edema. LSP is as effective as FFP, while offering many logistic advantages.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
22
0

Year Published

2014
2014
2020
2020

Publication Types

Select...
5
3

Relationship

3
5

Authors

Journals

citations
Cited by 30 publications
(23 citation statements)
references
References 37 publications
1
22
0
Order By: Relevance
“…This suggests that both neurologic and functional outcomes may be improved with the early use of plasma. These findings support recent large animal studies, (8,10), and highlight the need for further prospective research to ensure optimized neurologic outcomes in trauma patients with TBI.…”
Section: Discussionsupporting
confidence: 86%
“…This suggests that both neurologic and functional outcomes may be improved with the early use of plasma. These findings support recent large animal studies, (8,10), and highlight the need for further prospective research to ensure optimized neurologic outcomes in trauma patients with TBI.…”
Section: Discussionsupporting
confidence: 86%
“…Plasma has been shown to have multiple neuroprotective effects in traumatic brain injury. In a swine model of polytrauma, hemorrhagic shock, and TBI, both lyophilized plasma (LP) and FFP were shown to decrease brain lesion size by 50% after 6 h of injury when compared to saline infusion; swelling was also 54% less in plasma-treated groups [74]. A follow-up study to evaluate the long-term effects of resuscitation with FFP vs. LP on neurological outcomes showed similar recovery of cognitive function in studied animals.…”
Section: Neuroprotective Effects Of Lyophilized Plasmamentioning
confidence: 88%
“…In fact, our previous research has shown that early treatment with lyophilized plasma in a short-term model of TBI+HS offers the same neuroprotection as the conventional FFP (47). There is emerging evidence also that never-frozen, liquid plasma (LQP), which is approved for use for up to 26 days when stored at 1 to 6 °C, has an improved hemostatic profile (48) with decreased endothelial cell permeability compared to FFP (49).…”
Section: A C C E P T E D Accepted Manuscriptmentioning
confidence: 96%